Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

529 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
A Neutrophil Timer Coordinates Immune Defense and Vascular Protection.
Adrover JM, Del Fresno C, Crainiciuc G, Cuartero MI, Casanova-Acebes M, Weiss LA, Huerga-Encabo H, Silvestre-Roig C, Rossaint J, Cossío I, Lechuga-Vieco AV, García-Prieto J, Gómez-Parrizas M, Quintana JA, Ballesteros I, Martin-Salamanca S, Aroca-Crevillen A, Chong SZ, Evrard M, Balabanian K, López J, Bidzhekov K, Bachelerie F, Abad-Santos F, Muñoz-Calleja C, Zarbock A, Soehnlein O, Weber C, Ng LG, Lopez-Rodriguez C, Sancho D, Moro MA, Ibáñez B, Hidalgo A. Adrover JM, et al. Among authors: ibanez b. Immunity. 2019 Feb 19;50(2):390-402.e10. doi: 10.1016/j.immuni.2019.01.002. Epub 2019 Jan 29. Immunity. 2019. PMID: 30709741 Free article.
The future: therapy of myocardial protection.
Sanz-Rosa D, García-Prieto J, Ibanez B. Sanz-Rosa D, et al. Among authors: ibanez b. Ann N Y Acad Sci. 2012 Apr;1254:90-98. doi: 10.1111/j.1749-6632.2012.06501.x. Ann N Y Acad Sci. 2012. PMID: 22548574 Review.
Inactivation of nuclear factor-Y inhibits vascular smooth muscle cell proliferation and neointima formation.
Silvestre-Roig C, Fernández P, Esteban V, Pello ÓM, Indolfi C, Rodríguez C, Rodríguez-Calvo R, López-Maderuelo MD, Bauriedel G, Hutter R, Fuster V, Ibáñez B, Redondo JM, Martínez-González J, Andrés V. Silvestre-Roig C, et al. Among authors: ibanez b. Arterioscler Thromb Vasc Biol. 2013 May;33(5):1036-45. doi: 10.1161/ATVBAHA.112.300580. Epub 2013 Feb 21. Arterioscler Thromb Vasc Biol. 2013. PMID: 23430616
Exercise triggers ARVC phenotype in mice expressing a disease-causing mutated version of human plakophilin-2.
Cruz FM, Sanz-Rosa D, Roche-Molina M, García-Prieto J, García-Ruiz JM, Pizarro G, Jiménez-Borreguero LJ, Torres M, Bernad A, Ruíz-Cabello J, Fuster V, Ibáñez B, Bernal JA. Cruz FM, et al. Among authors: ibanez b. J Am Coll Cardiol. 2015 Apr 14;65(14):1438-50. doi: 10.1016/j.jacc.2015.01.045. J Am Coll Cardiol. 2015. PMID: 25857910 Free article.
Pathophysiology Underlying the Bimodal Edema Phenomenon After Myocardial Ischemia/Reperfusion.
Fernández-Jiménez R, García-Prieto J, Sánchez-González J, Agüero J, López-Martín GJ, Galán-Arriola C, Molina-Iracheta A, Doohan R, Fuster V, Ibáñez B. Fernández-Jiménez R, et al. Among authors: ibanez b. J Am Coll Cardiol. 2015 Aug 18;66(7):816-828. doi: 10.1016/j.jacc.2015.06.023. J Am Coll Cardiol. 2015. PMID: 26271065 Free article.
Neutrophil stunning by metoprolol reduces infarct size.
García-Prieto J, Villena-Gutiérrez R, Gómez M, Bernardo E, Pun-García A, García-Lunar I, Crainiciuc G, Fernández-Jiménez R, Sreeramkumar V, Bourio-Martínez R, García-Ruiz JM, Del Valle AS, Sanz-Rosa D, Pizarro G, Fernández-Ortiz A, Hidalgo A, Fuster V, Ibanez B. García-Prieto J, et al. Among authors: ibanez b. Nat Commun. 2017 Apr 18;8:14780. doi: 10.1038/ncomms14780. Nat Commun. 2017. PMID: 28416795 Free PMC article.
Lung ultrasound as a translational approach for non-invasive assessment of heart failure with reduced or preserved ejection fraction in mice.
Villalba-Orero M, López-Olañeta MM, González-López E, Padrón-Barthe L, Gómez-Salinero JM, García-Prieto J, Wai T, García-Pavía P, Ibáñez B, Jiménez-Borreguero LJ, Lara-Pezzi E. Villalba-Orero M, et al. Among authors: ibanez b. Cardiovasc Res. 2017 Aug 1;113(10):1113-1123. doi: 10.1093/cvr/cvx090. Cardiovasc Res. 2017. PMID: 28472392
Mirabegron, a Clinically Approved β3 Adrenergic Receptor Agonist, Does Not Reduce Infarct Size in a Swine Model of Reperfused Myocardial Infarction.
Rossello X, Piñero A, Fernández-Jiménez R, Sánchez-González J, Pizarro G, Galán-Arriola C, Lobo-Gonzalez M, Vilchez JP, García-Prieto J, García-Ruiz JM, García-Álvarez A, Sanz-Rosa D, Ibanez B. Rossello X, et al. Among authors: ibanez b. J Cardiovasc Transl Res. 2018 Aug;11(4):310-318. doi: 10.1007/s12265-018-9819-8. Epub 2018 Aug 2. J Cardiovasc Transl Res. 2018. PMID: 30073540
529 results